Low-level laser for prevention and therapy of oral mucositis induced by chemotherapy or radiotherapy

被引:44
作者
Genot, MT
Klastersky, J
机构
[1] Univ Libre Bruxelles, Ctr Tumeurs, Inst Jules Bordet, Laser Therapy Unit, Brussels, Belgium
[2] Univ Libre Bruxelles, Ctr Tumeurs, Inst Jules Bordet, Dept Med,Serv Med, Brussels, Belgium
[3] Univ Libre Bruxelles, Ctr Tumeurs, Inst Jules Bordet, Dept Med,Lab Invest Clin HJ Tagnon, Brussels, Belgium
关键词
adverse effects; bone marrow transplantation; chemotherapy; low-level laser; oral mucositis; radiotherapy;
D O I
10.1097/01.cco.0000156196.22249.76
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of review Oral mucositis is a common morbid condition associated with chemotherapy or radiotherapy for which there is no standard prophylaxis or treatment. There is increasing evidence that the use of low-level laser can reduced the severity of mucositis associated with chemotherapy or radiation therapy. The purpose of this review is to examine the available evidence for it. Recent findings For most approaches commonly used to prevent or treat chemotherapy-associated or radiotherapy-associated oral mucositis, a recent panel of experts could not find sufficient levels of evidence to recommend or suggest their use. As for low-level laser therapy, the results are difficult to assess and compare because of interoperator variability and because clinical trials are difficult to conduct in that field. Nevertheless, there is accumulating evidence in support of low-level laser therapy. Summary On the basis of literature data, it is reasonable to conclude that the evidence that low-level laser therapy may be useful in decreasing the severity of chemotherapy-associated or radiotherapy-associated mucositis is substantial, even though there have been few controlled studies in the field of prevention.
引用
收藏
页码:236 / 240
页数:5
相关论文
共 21 条
[1]  
BARASCH A, 1995, CANCER, V76, P2550, DOI 10.1002/1097-0142(19951215)76:12<2550::AID-CNCR2820761222>3.0.CO
[2]  
2-X
[3]   Low-energy He Ne laser in the prevention of radiation-induced mucositis - A multicenter phase III randomized study in patients with head and neck cancer [J].
Bensadoun, RJ ;
Franquin, JC ;
Ciais, G ;
Darcourt, V ;
Schubert, MM ;
Viot, M ;
Dejou, J ;
Tardieu, C ;
Benezery, K ;
Nguyen, TD ;
Laudoyer, Y ;
Dassonville, O ;
Poissonnet, G ;
Vallicioni, J ;
Thyss, A ;
Hamdi, M ;
Chauvel, P ;
Demard, F .
SUPPORTIVE CARE IN CANCER, 1999, 7 (04) :244-252
[4]   Mitochondrial membrane potential after low-power laser irradiation [J].
Bortoletto, R ;
Silva, NS ;
Zângaro, RA ;
Pacheco, MTT ;
Da Matta, RA ;
Pacheco-Soares, C .
LASERS IN MEDICAL SCIENCE, 2004, 18 (04) :204-206
[5]   Fibroblast growth factors in epithelial repair and cytoprotection [J].
Braun, S ;
Keller, UAD ;
Steiling, H ;
Werner, S .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2004, 359 (1445) :753-757
[6]  
CIAIS G, 1992, B CANCER, V79, P183
[7]   Low energy helium-neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: Results of a double blind randomized trial [J].
Cowen, D ;
Tardieu, C ;
Schubert, M ;
Peterson, D ;
Resbeut, M ;
Faucher, C ;
Franquin, JC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (04) :697-703
[8]   Oxidative stress induced in pathologies:: the role of antioxidants [J].
Gaté, L ;
Paul, J ;
Ba, GN ;
Tew, KD ;
Tapiero, H .
BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (04) :169-180
[9]  
GENOT MT, 2002, 14 MASCC INT S BOST
[10]  
GENOT MT, 2004, 16 MASCC INT S MIAM, V12